-Reuters
NaaS Technology Raises $21M Via Equity Offering To Certain Investors
NaaS Technology Inc (NASDAQ:NAAS) has completed $21 million of registered direct offering to certain investors, including Adrian Cheng and CST Group…
Related Posts
Newly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday – Read Here Why
Preliminary results of AEON Biopharma's Phase 2 trial for chronic migraine treatment reveal no significant improvement over placebo. Despite anticipated reductions in monthly migraine days, statistical significance was not reached, prompting a review of development strategies and financial measures.
Harpoon Therapeutics To Present Interim Results From Phase 1 Clinical Trial Of T Cell Engager HPN217 At The 64th ASH Annual Meeting And Exposition
Harpoon Therapeutics, Inc. (NASDAQ:HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced that it will present updated interim data from its Phase 1 clinical trial evaluating
VA And DoD Face Criticism From Rep. Blumenauer Over ‘Misguided’ Denial Of PTSD Treatment With Medical Cannabis
In an urgent appeal to rethink current medical marijuana policies, Rep. Earl Blumenauer (D-OR), has criticized the U.S.